Nyxoah S.A. (NYXH)

USD 7.94

(-0.63%)

Market Cap (In USD)

272.82 Million

Revenue (In USD)

4.34 Million

Net Income (In USD)

-43.21 Million

Avg. Volume

10.62 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.0-20.0
PE
-
EPS
-
Beta Value
0.548
ISIN
BE0974358906
CUSIP
-
CIK
1857190
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Olivier Taelman
Employee Count
-
Website
https://www.nyxoah.com
Ipo Date
2021-04-28
Details
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.